Ground Swell Capital LLC Makes New $979,000 Investment in Astera Labs, Inc. $ALAB

Ground Swell Capital LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 5,000 shares of the company’s stock, valued at approximately $979,000. Astera Labs accounts for approximately 2.1% of Ground Swell Capital LLC’s investment portfolio, making the stock its 8th largest position.

Several other large investors also recently modified their holdings of the company. Royal Bank of Canada raised its stake in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the period. Janney Montgomery Scott LLC acquired a new position in shares of Astera Labs in the 2nd quarter valued at about $559,000. Finally, US Bancorp DE boosted its position in shares of Astera Labs by 222.8% during the 2nd quarter. US Bancorp DE now owns 9,978 shares of the company’s stock valued at $902,000 after purchasing an additional 6,887 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 beat on revenue and EPS with strong growth and margins — the company reported $270.6M revenue, 75.7% gross margin and an EPS beat, and management issued solid Q1 guidance that underscores hyperscaler demand. ALAB Q4 Earnings Beat (Zacks)
• Positive Sentiment: Wall‑street analysts still see upside tied to large AI infrastructure customers (NVIDIA, AMD, Amazon, Google) and JPMorgan highlighted Astera as a beneficiary of AI buildout. That underpins medium‑term demand expectations. JPMorgan Upside Note (Benzinga)
• Neutral Sentiment: Analysts/transcripts available — full earnings call transcript and Seeking Alpha pieces provide granular color on product ramps (Scorpio X) and margin trajectory; read if you need detail on guidance cadence into H2/2027. Earnings Analysis & Transcript (Seeking Alpha)
• Neutral Sentiment: Reported short‑interest entries appear to be data anomalies (values show 0 and NaN); no actionable evidence of a meaningful short squeeze or buildup from the published figures. Earnings Call Transcript (MSN)
• Negative Sentiment: Investors are booking profits after a massive run-up; several outlets flagged profit‑taking and a “rich” valuation as reasons for the selloff despite the beat. Profit‑Taking After Earnings (Seeking Alpha)
• Negative Sentiment: Concerns about concentration and deal terms: coverage highlighted Amazon’s reported $6.5B engagement as a “double‑edged sword” (big revenue opportunity but customer concentration/contract risk), which weighed on sentiment. Amazon Deal Concerns (MarketWatch)
• Negative Sentiment: CFO change and other corporate developments introduced near‑term uncertainty; several writeups linked management changes to the intra‑day weakness as investors reassessed execution risk. Slide After Earnings, CFO Change (Benzinga)

Analyst Upgrades and Downgrades

ALAB has been the topic of several recent analyst reports. Barclays set a $165.00 price target on Astera Labs in a research note on Thursday, January 15th. Royal Bank Of Canada initiated coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Raymond James Financial initiated coverage on shares of Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating for the company. Finally, TD Cowen reissued a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $192.89.

Astera Labs Trading Down 11.9%

ALAB opened at $126.58 on Friday. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The company has a market cap of $21.38 billion, a price-to-earnings ratio of 103.75, a PEG ratio of 1.96 and a beta of 1.50. The company’s fifty day moving average price is $164.73 and its two-hundred day moving average price is $174.08.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business’s revenue was up 91.8% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief operating officer owned 1,599,750 shares in the company, valued at $231,467,827.50. This represents a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 576,936 shares of company stock worth $87,409,540. Company insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.